Stefanos Theoharis | Chief Executive Officer
OneChain Immunotherapeutics

Stefanos, CEO of OneChain Immunotherapeutics, the leading CAR-T company in Spain, brings over 20 years of broad experience in the cell and gene therapy space, BD, program management, manufacturing, and basic research. Prior to that he was Venture Partner at Albion VC and Deep Science Ventures, in London. Formerly, CBO of Bone Therapeutics, developing specialized cell therapies for orthopaedic disorders, SVP, BD at Cell Medica, and CBO at apceth GmbH. He also held positions as and Director of BD at Roche, focused on partnering in emerging science and technologies, and Lazard, the global investment bank.